Nothing Special   »   [go: up one dir, main page]

Kingdon, 1969 - Google Patents

Evolution of enzyme activities and fibrin formation after contact of plasma with glass

Kingdon, 1969

Document ID
16383731571340312588
Author
Kingdon H
Publication year
Publication venue
Journal of Biomedical Materials Research

External Links

Snippet

At least ten proteins play a role in normal blood coagulation. Nine of these are important in coagulation promoted by contact with glass, and are probably involved in coagulation triggered by other surfaces. These proteins have been established as separate entities by …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)

Similar Documents

Publication Publication Date Title
Hultin et al. Activation of factor X by factors IXa and VIII; a specific assay for factor IXa in the presence of thrombin-activated factor VIII
Sas et al. Abnormal antithrombin III (antithrombin III ‘Budapest’) as a cause of a familial thrombophilia
Dahlback et al. Binding of bovine coagulation factor Xa to platelets
Niewiarowski et al. Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interaction with platelets and plasma-clotting factors
Katayama et al. Comparison of amino acid sequence of bovine coagulation Factor IX (Christmas Factor) with that of other vitamin K-dependent plasma proteins.
Huseby et al. Synthetic Oligopeptide Substrates Their Diagnostic Application in Blood Coagulation, Fibrinolysis, and Other Pathologic States
Lundblad et al. The activation of Stuart factor (factor X) by activated antihemophilic factor (activated factor VIII)
Kingdon Evolution of enzyme activities and fibrin formation after contact of plasma with glass
Harpel Studies on the Interaction between Collagen and a Plasma Kallikrein-Like Activity EVIDENCE FOR A SURFACE-ACTIVE ENZYME SYSTEM
Mcdonagh et al. Alternative pathways for the activation of factor XIII
PT907724E (en) Von willebrand factor multimerase
Ouyang et al. Properties of fibrinogen degradation products produced by α-and β-fibrinogenases of Trimeresurus mucrosquamatus snake venom
Aronson Factor IX complex
EP0216891A1 (en) A solubilizable, fibrin based composition and its use.
Mui et al. Isolation and properties of a low molecular weight antiplasmin of human blood platelets and serum
Bezeaud et al. Prothrombin Salakta: an abnormal prothrombin characterized by a defect in the active site of thrombin
Seegers et al. Inactivation of purified autoprothrombin I with antithrombin
Novoa et al. Improved procedures for the purification of selected vitamin K-dependent proteins
Lewis et al. Effects of Epsilon Aminocaproic Acid on Coagulation and Fibrinolytic Mechanisms: Studies of epsilon aminocaproic acid therapy in cirrhotic patients without gross bleeding tendencies suggest that the low factor V levels found in liver disease are caused by decreased production, not by increased destruction
PT95193A (en) METHOD FOR ACTIVITY OF PROTEIN C
Silberman et al. Effects of ancrod (Arvin) in mice: studies of plasma fibrinogen and fibrinolytic activity
Sakuragawa et al. Significance of a prothrombin assay method using Echis carinatus venom for diagnostic information in disseminated intravascular coagulation syndrome
Aznar et al. Fibrinogen Valencia A New Case of Congenital Dysfibrinogenemia
Stachurska et al. Effects of proteolytic degradation products of human fibrinogen and of human factor VIII on platelet aggregation and vascular permeability
Iatridis et al. Blood clotting activities of thrombolytic agents with special reference to a Hageman-like effect